Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  PerkinElmer, Inc.    PKI

Delayed Quote. Delayed  - 09/23 10:04:10 pm
55.53 USD   -0.14%
02:05p PERKINELMER : Announces New Organizational Structure
09/02 PERKINELMER : launches ChemDraw® cloud platform at 2016 ACS Fall Nat..
09/01 PERKINELMER : to Present at Morgan Stanley Global Healthcare Confere..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

PerkinElmer, Inc. : PerkinElmer Board Declares Quarterly Dividend

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/25/2013 | 10:10pm CEST

The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on January 25, 2013. This dividend is payable on May 10, 2013, to all shareholders of record at the close of business on April 19, 2013.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The company reported revenue of approximately $1.9 billion in 2011, has about 7,400 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

Investor Relations:
PerkinElmer, Inc.
Tommy J. Thomas, 781-663-5889
tommy.thomas@perkinelmer.com
or
Media Contact:
PerkinElmer, Inc.
Stephanie R. Wasco, 781-663-5701
stephanie.wasco@perkinelmer.com


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PERKINELMER, INC.
02:05p PERKINELMER : Announces New Organizational Structure
09/22 PERKINELMER : Presolicitation Notice - Support Agreement for Perkinelmer Instrum..
09/02 PERKINELMER : launches ChemDraw® cloud platform at 2016 ACS Fall National Meetin..
09/01 PERKINELMER : to Present at Morgan Stanley Global Healthcare Conference
08/30 PERKINELMER : Webinar Spotlights Advanced Analysis of Complex Cell Models with N..
08/29 PERKINELMER : Webinar Spotlights Advanced Analysis of Complex Cell Models with N..
08/25 PERKINELMER : Research Report Initiation on These Healthcare Stocks -- VWR Corp...
08/12 PERKINELMER INC : Entry into a Material Definitive Agreement, Termination of a M..
08/12 PERKINELMER : Webinar Highlights Emerging Applications in Preclinical MicroCT Im..
08/11 PERKINELMER : Webinar Highlights Emerging Applications in Preclinical MicroCT Im..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
09/01DJPHILIPS : Appoints IBM Executive Sophie Bechu as Operations Head
08/17DJAGILENT TECHNOLOGIES : Tech Tapers Annual Outlook Amid Slowing Life Sciences Sal..
08/15DJFisher & Paykel Files Patent Infringement Claim Against ResMed
08/02DJCERNER : Edges Annual Revenue Guidance Lower
07/29DJSony Reports Surprise Profit
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
08/05 PerkinElmer, Inc. 2016 Q4 - Results - Earnings Call Slides
08/04 PerkinElmer (United States) (PKI) Robert F. Friel on Q2 2016 Results - Earnin..
08/04 PerkinElmer beats by $0.01, misses on revenue
08/04 Baebies Is An FDA Attention Seeker
08/03 Notable earnings after Thursday?s close
Advertisement
Financials ($)
Sales 2016 2 316 M
EBIT 2016 410 M
Net income 2016 262 M
Debt 2016 680 M
Yield 2016 0,50%
P/E ratio 2016 23,60
P/E ratio 2017 20,77
EV / Sales 2016 2,92x
EV / Sales 2017 2,71x
Capitalization 6 075 M
More Financials
Chart PERKINELMER, INC.
Duration : Period :
PerkinElmer, Inc. Technical Analysis Chart | PKI | US7140461093 | 4-Traders
Full-screen chart
Technical analysis trends PERKINELMER, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Average target price 56,4 $
Spread / Average Target 1,5%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Robert F. Friel Chairman, President & Chief Executive Officer
Frank Anders Wilson Chief Financial Officer & Senior Vice President
Nicholas A. Lopardo Independent Director
Alexis Platon Michas Lead Independent Director
Vicki L. Sato Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PERKINELMER, INC.3.66%6 075
THERMO FISHER SCIENTIF..11.15%62 159
BOSTON SCIENTIFIC CORP..28.58%32 263
PHILIPS12.92%28 328
INTUITIVE SURGICAL, IN..30.04%27 339
ILLUMINA, INC.-6.57%26 290
More Results